Roche&39;s Tecentriq Positive But Not Perfect In IMpower130 Firstline Lung Cancer Study

Roche's Tecentriq Positive But Not Perfect In IMpower130 First-line Lung Cancer Study

18:03 EDT 22 Oct 2018 | SCRIP

Combination with Abraxane demonstrates an overall survival benefit on top of progression-free survival, but Merck's competing Keytruda has set a...